, Tracking Stock Market Picks
Enter Symbol:
3sbio Inc. (SSRX) [hlAlert]

up 36.99 %

3sbio Inc. (SSRX) rated Overweight with price target $19.90 by HSBC Securities

Posted on: Friday,  Sep 21, 2012  8:25 AM ET by HSBC Securities

HSBC Securities rated Overweight 3sbio Inc. (NASDAQ: SSRX) on 09/21/2012. Previously HSBC Securities rated Overweight 3sbio Inc. (NASDAQ: SSRX) on 07/13/2012.,
when the stock price was $12.11. Since then, 3sbio Inc. has gained 36.99% as of 05/29/2016's recent price of $16.59.
If you would have followed the previous HSBC Securities's recommendation on SSRX, you would have gained 36.99% of your investment in 1416 days.

3SBio Inc. is an integrated biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products primarily in China. The Company?s recombinant, or genetically engineered, protein-based products and product candidates are designed to address markets with unmet medical needs in nephrology, oncology, supportive cancer care, inflammation and infectious diseases. Its principal products are EPIAO and TPIAO, and its legacy products are Intefen and Inleusin. EPIAO is an injectable recombinant human erythropoietin (EPO) that is used to stimulate the production of red blood cells in patients with anemia and to reduce the need for blood transfusions. 3SBio Inc. had launched TPIAO, its internally developed protein-based therapeutic product. In addition to EPIAO and TPIAO, the Company markets two other protein-based therapeutics.

HSBC has refined and refocused its Global Equities organisation, creating a lean and flexible business model built to meet the needs of global issuers and investors today and in the future. Acknowledging the changing demands of clients, we have also refined our research model, moving away from traditional maintenance to focus on long term, thematic research (a two-year-plus horizon) combined with short term (zero to three months), real-time, actionable ideas both for companies and sectors.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
9/21/2012 8:25 AM Buy
13.39 19.90
as of 12/31/2012
1 Week down  -0.87 %
1 Month up  3.33 %
3 Months up  5.00 %
1 YTD up  1.86 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
7/13/2012 8:25 AM Buy
12.11 17.60

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy